Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03980145 · ClinicalTrials.gov registry record · NA
G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03980145 is a NA study that has completed, run by Indiana University. The registered enrollment target is 15 participants.
The verdict
NCT03980145, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The logistic advantages and advanced training capabilities of the G-EO System, as well as the benefits reported in other populations, support this strategy as a potentially potent rehabilitation tool for restoring and maintaining function in progressive Multiple Sclerosis (MS). This approach represents a paradigm shifting opportunity for improving current clinical practices for patients with progressive MS. If successful, this project will provide initial evidence for increasing patient access to the G-EO System, and this could be accomplished through "regional technology centers" using a rural health-delivery approach. There are several novel aspects of the proposed trial: (1) the examination of a novel gait rehabilitation stimulus (G-EO System) that could alter current clinical practices; (2) the focus on patients with progressive MS who have gait impairment (i.e., those who have received minimal research attention), which was recently described as the greatest therapeutic challenge facing the MS community; and (3) a study design that accounts for standard therapy. Specific Aims: The investigators designed a single-blinded, randomized pilot trial of electromechanically-assisted gait training using the G-EO System in patients with progressive MS with gait disability (EDSS=4.0-7.5). Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, symptomatic, quality of life, and participatory outcomes.
Interventions
- OTHER Conventional Physical Therapy
- DEVICE G-EO System (Reha Technology AG: Olten, Switzerland)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-05-02 |
| Est. Completion | 2020-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03980145
The ClinicalTrials.gov registry entry for NCT03980145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Conventional Physical Therapy is the first listed.
NCT03980145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03980145 about?
NCT03980145 is a clinical study titled "G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis". The logistic advantages and advanced training capabilities of the G-EO System, as well as the benefits reported in other populations, support this strategy as a potentially potent rehabilitation tool for restoring and maintaining function in progressive Multiple Sclerosis (MS). This approach represe...
What is the current status of trial NCT03980145?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-05-02. Estimated completion is 2020-03-01.
What interventions are being tested in trial NCT03980145?
The interventions under investigation include: Conventional Physical Therapy (OTHER), G-EO System (Reha Technology AG: Olten, Switzerland) (DEVICE).
Who is sponsoring clinical trial NCT03980145?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.